# Clipper Realty Inc.: financial statements, quarterly

CLPR · NYSE · CIK 1649096 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/clpr.md) · [Financials](/companies/clpr/financials.md) · [Filings](/companies/clpr/filings.md) · [Insiders](/companies/clpr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/clpr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [35.1](/filings/0001437749-24-032782.md) | [34.9 d](/filings/0001437749-25-003988.md) | [35.8](/filings/0001437749-25-016113.md) | [37.3](/filings/0001437749-25-025574.md) | [37.6](/filings/0001437749-25-034911.md) | [38.0 d](/filings/0001437749-26-005856.md) | [39.4](/filings/0001437749-26-017036.md) | [39.0](/filings/0001437749-26-026249.md) | [37.7](/filings/0001437749-25-034911.md) | [37.1 d](/filings/0001437749-26-005856.md) | [38.1](/filings/0001437749-26-017036.md) | [38.6](/filings/0001437749-26-026249.md) |
| Cost of revenue | $m | [25.9](/filings/0001437749-24-032782.md) | [25.9 d](/filings/0001437749-25-003988.md) | [26.7](/filings/0001437749-25-016113.md) | [27.3](/filings/0001437749-25-025574.md) | [26.9](/filings/0001437749-25-034911.md) | [27.1 d](/filings/0001437749-26-005856.md) | [63.0](/filings/0001437749-26-017036.md) | [28.2](/filings/0001437749-26-026249.md) | [28.8](/filings/0001437749-25-034911.md) | [29.0 d](/filings/0001437749-26-005856.md) | [30.1](/filings/0001437749-26-017036.md) | [29.0](/filings/0001437749-26-026249.md) |
| Operating income | $m | [9.2](/filings/0001437749-24-032782.md) | [9.0 d](/filings/0001437749-25-003988.md) | [9.1](/filings/0001437749-25-016113.md) | [10.0](/filings/0001437749-25-025574.md) | [10.8](/filings/0001437749-25-034911.md) | [10.7 d](/filings/0001437749-26-005856.md) | [(23.6)](/filings/0001437749-26-017036.md) | [10.8](/filings/0001437749-26-026249.md) | [8.9](/filings/0001437749-25-034911.md) | [8.1 d](/filings/0001437749-26-005856.md) | [4.4](/filings/0001437749-26-017036.md) | [9.4](/filings/0001437749-26-026249.md) |
| Interest expense | $m | [11.5](/filings/0001437749-23-030021.md) | [11.9 d](/filings/0001437749-25-003988.md) | [11.7](/filings/0001437749-24-015069.md) | [11.7](/filings/0001437749-25-025574.md) | [11.8](/filings/0001437749-25-034911.md) | [11.8 d](/filings/0001437749-26-005856.md) | [11.5](/filings/0001437749-26-017036.md) | [11.5](/filings/0001437749-26-026249.md) | [13.3](/filings/0001437749-25-034911.md) | [16.7 d](/filings/0001437749-26-005856.md) | [15.5](/filings/0001437749-26-017036.md) | [15.7](/filings/0001437749-26-026249.md) |
| Income tax | $m | [0.0 d](/filings/0001437749-24-032782.md) | [0.0 d](/filings/0001437749-24-007842.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0001437749-25-016113.md) | [0.0 d](/filings/0001437749-25-025574.md) | [0.0 d](/filings/0001437749-25-034911.md) | [0.0 d](/filings/0001437749-26-005856.md) | [0.0](/filings/0001437749-26-017036.md) | [0.0 d](/filings/0001437749-26-026249.md) |
| Net income | $m | [(2.3)](/filings/0001437749-24-032782.md) | [(2.9) d](/filings/0001437749-25-003988.md) | [(2.7)](/filings/0001437749-25-034911.md) | [(1.7)](/filings/0001437749-25-034911.md) | [(1.1)](/filings/0001437749-25-034911.md) | [(1.1) d](/filings/0001437749-26-005856.md) | [(35.1)](/filings/0001437749-26-026249.md) | [(1.4)](/filings/0001437749-26-026249.md) | [(4.6)](/filings/0001437749-25-034911.md) | [(11.3) d](/filings/0001437749-26-005856.md) | [(11.1)](/filings/0001437749-26-026249.md) | [(6.3)](/filings/0001437749-26-026249.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [(0.86)](/filings/0001437749-26-017036.md) | [(0.07)](/filings/0001437749-26-026249.md) | not reported | not reported | [(0.30)](/filings/0001437749-26-017036.md) | not reported |
| Basic EPS | $ per share | [(0.09)](/filings/0001437749-24-032782.md) | not reported | [(0.09)](/filings/0001437749-25-016113.md) | [(0.06)](/filings/0001437749-25-025574.md) | [(0.05)](/filings/0001437749-25-034911.md) | not reported | [(0.86)](/filings/0001437749-26-017036.md) | [(0.07)](/filings/0001437749-26-026249.md) | [(0.14)](/filings/0001437749-25-034911.md) | not reported | [(0.30)](/filings/0001437749-26-017036.md) | [(0.19)](/filings/0001437749-26-026249.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [22.5](/filings/0001437749-24-032782.md) | [22.2](/filings/0001437749-26-005856.md) | [21.9](/filings/0001437749-25-016113.md) | [20.3](/filings/0001437749-25-025574.md) | [18.6](/filings/0001437749-25-034911.md) | [19.9](/filings/0001437749-26-026249.md) | [21.3](/filings/0001437749-26-017036.md) | [32.0](/filings/0001437749-26-026249.md) | [26.1](/filings/0001437749-25-034911.md) | [30.8](/filings/0001437749-26-026249.md) | [26.1](/filings/0001437749-26-017036.md) | [37.7](/filings/0001437749-26-026249.md) |
| Total assets | $m | [1,240](/filings/0001437749-23-030021.md) | [1,249](/filings/0001437749-25-003988.md) | [1,264](/filings/0001437749-24-015069.md) | [1,275](/filings/0001437749-24-024284.md) | [1,287](/filings/0001437749-24-032782.md) | [1,287](/filings/0001437749-26-005856.md) | [1,262](/filings/0001437749-25-016113.md) | [1,241](/filings/0001437749-25-025574.md) | [1,238](/filings/0001437749-25-034911.md) | [1,234](/filings/0001437749-26-026249.md) | [1,226](/filings/0001437749-26-017036.md) | [1,221](/filings/0001437749-26-026249.md) |
| Total liabilities | $m | [1,226](/filings/0001437749-23-030021.md) | [1,242](/filings/0001437749-25-003988.md) | [1,263](/filings/0001437749-24-015069.md) | [1,279](/filings/0001437749-24-024284.md) | [1,296](/filings/0001437749-24-032782.md) | [1,301](/filings/0001437749-26-005856.md) | [1,315](/filings/0001437749-25-016113.md) | [1,299](/filings/0001437749-25-025574.md) | [1,304](/filings/0001437749-25-034911.md) | [1,315](/filings/0001437749-26-026249.md) | [1,322](/filings/0001437749-26-017036.md) | [1,326](/filings/0001437749-26-026249.md) |
| Long-term debt | $m | [1,197](/filings/0001437749-23-030021.md) | [1,206](/filings/0001437749-25-003988.md) | [1,227](/filings/0001437749-24-015069.md) | [1,244](/filings/0001437749-24-024284.md) | [1,258](/filings/0001437749-24-032782.md) | [1,266](/filings/0001437749-25-016113.md) | [1,273](/filings/0001437749-25-016113.md) | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [5.2](/filings/0001437749-23-030021.md) | [2.7](/filings/0001437749-25-003988.md) | [0.3](/filings/0001437749-24-015069.md) | [(1.8)](/filings/0001437749-24-024284.md) | [(3.6)](/filings/0001437749-24-032782.md) | [(5.4)](/filings/0001437749-26-005856.md) | [(20.1)](/filings/0001437749-25-016113.md) | [(21.9)](/filings/0001437749-25-025574.md) | [(25.0)](/filings/0001437749-25-034911.md) | [(30.7)](/filings/0001437749-26-026249.md) | [(36.3)](/filings/0001437749-26-017036.md) | [(40.1)](/filings/0001437749-26-026249.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.1) d](/filings/0001437749-24-032782.md) | [9.1 d](/filings/0001437749-25-003988.md) | [6.3](/filings/0001437749-25-016113.md) | [8.8 d](/filings/0001437749-25-025574.md) | [6.3 d](/filings/0001437749-25-034911.md) | [10.5 d](/filings/0001437749-26-005856.md) | [6.7](/filings/0001437749-26-017036.md) | [8.4 d](/filings/0001437749-26-026249.md) | [1.4 d](/filings/0001437749-25-034911.md) | [6.1 d](/filings/0001437749-26-005856.md) | [3.6](/filings/0001437749-26-017036.md) | [14.4 d](/filings/0001437749-26-026249.md) |
| Capital expenditure | $m | [10.8](/filings/0001437749-23-030021.md) | [18.0 d](/filings/0001437749-25-003988.md) | [20.9](/filings/0001437749-25-016113.md) | not reported | not reported | not reported | [11.3](/filings/0001437749-25-016113.md) | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [4.3 d](/filings/0001437749-24-032782.md) | [4.4 d](/filings/0001437749-25-003988.md) | not reported | not reported | [4.4 d](/filings/0001437749-25-034911.md) | [4.4 d](/filings/0001437749-26-005856.md) | [0.0](/filings/0001437749-26-017036.md) | [9.2 d](/filings/0001437749-26-026249.md) | [4.6 d](/filings/0001437749-25-034911.md) | [4.6 d](/filings/0001437749-26-005856.md) | [4.7](/filings/0001437749-26-017036.md) | [4.7 d](/filings/0001437749-26-026249.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.1](/filings/0001437749-26-017036.md) | [16.1](/filings/0001437749-26-026249.md) | [16.2](/filings/0001437749-26-017036.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,157,566 at 2026-08-06, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026249.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.